News
We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Merck & ...
Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Marjorie Green, senior vice president and head of ...
The May editions feature insights from Avery Dennison, Graphite Connect, Merck KGaA, Grupo Herdez, SEAT, UPS and others, exploring supply chain resilience, procurement transformation and the ...
New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...
The S&P 500, the Dow Jones, and the NASDAQ all moved between 0.8% and 1% lower by mid-afternoon. Palantir (PLTR) stock ...
Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...
Merck & Co. is strutting into the spotlight as a top contender among the most profitable cheap stocks, thanks to its robust ...
During a recent sit-down interview with The News Journal, Gov. Matt Meyer discussed changes to how schools are funded in ...
The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...
Merck is injecting $1 billion into a new facility in Wilmington, Delaware to amp up U.S. drug production, especially for its ...
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results